Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 May;83(10):3321–3325. doi: 10.1073/pnas.83.10.3321

Platelets contain a peptide inhibitor of endothelial cell replication and growth.

M T Brown, D R Clemmons
PMCID: PMC323505  PMID: 3517856

Abstract

Platelets release specific growth factors that stimulate division of aortic endothelial cells. Acidification or heating to 56 degrees C of platelet extracts is required to detect these factors. Nonheated platelet extracts inhibit endothelial growth. To determine if this inhibitory effect is due to a discrete chemical substance, a crude extract obtained by freezing and thawing human platelets was incubated with an endothelial cell mitogen and found to inhibit the endothelial cell incorporation of [3H]thymidine by greater than 95%. The inhibitor was partially purified by ion-exchange and gel-filtration chromatography. The partially purified material inhibited endothelial cell division as well as DNA synthesis. Inhibition caused by the partially purified material was concentration dependent, reversible, and not due to cytotoxicity. Further purification by heparin-Sepharose chromatography resulted in removal of greater than 95% of the contaminating substances without a loss of inhibitory activity. Physical characterization revealed that heparin-Sepharose-purified factor was heat labile, had a molecular size estimated at 35-40 kDa, and was stable between pH 4.5 and 9.0. Treatment with proteolytic enzymes destroyed all biologic activity, suggesting a peptide composition. These data support the conclusion that platelets contain a potent inhibitor of endothelial replication and growth. Since platelet deposition and release occur after endothelial denudation, release of this platelet-derived growth inhibitor may be an important regulator of reendothelialization that occurs after vessel injury.

Full text

PDF
3321

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams R. L. The effect of endogenous pools of thymidylate on the apparent rate of DNA synthesis. Exp Cell Res. 1969 Jul;56(1):55–58. doi: 10.1016/0014-4827(69)90393-0. [DOI] [PubMed] [Google Scholar]
  2. Antoniades H. N., Scher C. D., Stiles C. D. Purification of human platelet-derived growth factor. Proc Natl Acad Sci U S A. 1979 Apr;76(4):1809–1813. doi: 10.1073/pnas.76.4.1809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brem H., Folkman J. Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med. 1975 Feb 1;141(2):427–439. doi: 10.1084/jem.141.2.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Castellot J. J., Jr, Favreau L. V., Karnovsky M. J., Rosenberg R. D. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase. J Biol Chem. 1982 Oct 10;257(19):11256–11260. [PubMed] [Google Scholar]
  5. Clemmons D. R., Isley W. L., Brown M. T. Dialyzable factor in human serum of platelet origin stimulates endothelial cell replication and growth. Proc Natl Acad Sci U S A. 1983 Mar;80(6):1641–1645. doi: 10.1073/pnas.80.6.1641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cotta-Pereira G., Sage H., Bornstein P., Ross R., Schwartz S. Studies of morphologically atypical ("sprouting") cultures of bovine aortic endothelial cells. Growth characteristics and connective tissue protein synthesis. J Cell Physiol. 1980 Feb;102(2):183–191. doi: 10.1002/jcp.1041020209. [DOI] [PubMed] [Google Scholar]
  7. Fenselau A., Watt S., Mello R. J. Tumor angiogenic factor. Purification from the Walker 256 rat tumor. J Biol Chem. 1981 Sep 25;256(18):9605–9611. [PubMed] [Google Scholar]
  8. Gospodarowicz D., Brown K. D., Birdwell C. R., Zetter B. R. Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin. J Cell Biol. 1978 Jun;77(3):774–788. doi: 10.1083/jcb.77.3.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. King G. L., Buchwald S. Characterization and partial purification of an endothelial cell growth factor from human platelets. J Clin Invest. 1984 Feb;73(2):392–396. doi: 10.1172/JCI111224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kohler N., Lipton A. Platelets as a source of fibroblast growth-promoting activity. Exp Cell Res. 1974 Aug;87(2):297–301. doi: 10.1016/0014-4827(74)90484-4. [DOI] [PubMed] [Google Scholar]
  11. Pearson J. D., Olverman H. J., Gordon J. L. Transport of 5-hydroxytryptamine by endothelial cells [proceedings]. Biochem Soc Trans. 1977;5(4):1181–1183. doi: 10.1042/bst0051181. [DOI] [PubMed] [Google Scholar]
  12. Raymond L., Jacobson B. Isolation and identification of stimulatory and inhibitory cell growth factors in bovine vitreous. Exp Eye Res. 1982 Feb;34(2):267–286. doi: 10.1016/0014-4835(82)90060-4. [DOI] [PubMed] [Google Scholar]
  13. Ross R., Glomset J., Kariya B., Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1207–1210. doi: 10.1073/pnas.71.4.1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ross R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol. 1971 Jul;50(1):172–186. doi: 10.1083/jcb.50.1.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schwartz S. M. Selection and characterization of bovine aortic endothelial cells. In Vitro. 1978 Dec;14(12):966–980. doi: 10.1007/BF02616210. [DOI] [PubMed] [Google Scholar]
  16. Thorgeirsson G., Robertson A. L., Jr Platelet factors and the human vascular wall: variations in growth response between endothelial and medial smooth muscle cells. Atherosclerosis. 1978 May;30(1):67–78. doi: 10.1016/0021-9150(78)90153-3. [DOI] [PubMed] [Google Scholar]
  17. Tucker R. F., Shipley G. D., Moses H. L., Holley R. W. Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science. 1984 Nov 9;226(4675):705–707. doi: 10.1126/science.6093254. [DOI] [PubMed] [Google Scholar]
  18. Wall R. T., Harker L. A., Quadracci L. J., Striker G. E. Factors influencing endothelial cell proliferation in vitro. J Cell Physiol. 1978 Aug;96(2):203–213. doi: 10.1002/jcp.1040960209. [DOI] [PubMed] [Google Scholar]
  19. Willems C., Astaldi G. C., De Groot P. G., Janssen M. C., Gonsalvez M. D., Zeijlemaker W. P., Van Mourik J. A., Van Aken W. G. Media conditioned by cultured human vascular endothelial cells inhibit the growth of vascular smooth muscle cells. Exp Cell Res. 1982 May;139(1):191–197. doi: 10.1016/0014-4827(82)90332-9. [DOI] [PubMed] [Google Scholar]
  20. Zetter B. R., Antoniades H. N. Stimulation of human vascular endothelial cell growth by a platelet-derived growth factor and thrombin. J Supramol Struct. 1979;11(3):361–370. doi: 10.1002/jss.400110311. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES